Secondary genetic alterations in both molecular subsets of MCL identified by WES/WGS
Feature . | Gene . | MCL overall (%) . | cMCL (%) . | nnMCL (%) . | P value . |
---|---|---|---|---|---|
ATM | 38 | 58 | 0 | <.001∗ | |
Del ATM | 27 | 36 | 0 | <.001∗ | |
Del TP53 | 23 | 14 | 30 | .171 | |
DDR and telomere maintenance | TP53 | 22 | 15 | 25 | .328 |
TERT† | 15 | 10 | 25 | .567 | |
SAMHD1 | 3 | 8 | 0 | .322 | |
del 9p21 (CDKN2A/B) | 31 | 25 | 0 | .009∗ | |
Del 13q14 (RB1) | 25 | 31 | 0 | .004∗ | |
3' UTR CCND1 | 18 | 20 | 15 | NA | |
CCND1 | 16 | 8 | 85 | <.001∗ | |
Gain 8q24 (MYC) | 16 | 12 | 5 | .672 | |
Cell cycle and survival | Gain 12q13 (CDK4) | 13 | 17 | 0 | .058 |
Gain 18q2 (BCL2) | 12 | 19 | 0 | .057 | |
Gain CCND1 | 11 | 14 | 0 | .192 | |
Gain 13q31 (MIR17HG) | 10 | 12 | 0 | .182 | |
Gain 10p12 (BMI1) | 9 | 12 | 0 | .182 | |
KMT2D | 15 | 19 | 0 | .057 | |
NSD2 | 13 | 17 | 0 | .058 | |
Chromatin remodelers | SMARCA4 | 8 | 12 | 0 | .182 |
SP140 | 6 | 8 | 0 | .322 | |
KMT2C | 6 | 0 | 0 | NA | |
BIRC3 | 5 | 5 | 5 | 1 | |
BCR/NF-κB/TLR | CARD11 | 1 | 5 | 5 | 1 |
TRAF2 | 3 | 2 | 0 | .062 | |
NOTCH1 | 7 | 5 | 5 | 1 | |
NOTCH signaling | NOTCH2 | 6 | 5 | 0 | .567 |
UBR5 | 8 | 7 | 0 | .567 | |
SYNE1 | 3 | 5 | 10 | .596 | |
DLC1 | 3 | 2 | 0 | .062 | |
Other | HNRNPH1 | 2 | 7 | 5 | 1 |
MEF2B | 2 | 7 | 0 | .567 | |
S1PR1 | 2 | 5 | 0 | .322 | |
BCOR | 1 | 7 | 0 | .567 | |
Gain 3q25-q29 | 40 | 49 | 10 | .003∗ | |
Del 13q33-q34 | 30 | 42 | 5 | .002∗ | |
Del 1p22 | 30 | 10 | 0 | <.001∗ | |
Del 6q | 20 | 34 | 5 | .017∗ | |
Del 9q22-q31 | 18 | 24 | 0 | .009∗ | |
CNA | Del 8p | 17 | 10 | 5 | .672 |
10p15-p13 del | 15 | 20 | 0 | .031 | |
Del 15q11-q13 | 11 | 12 | 0 | .182 | |
Gain 15q21-q25 | 10 | 10 | 5 | .672 | |
Gain 7p | 9 | 20 | 0 | .031 |
Feature . | Gene . | MCL overall (%) . | cMCL (%) . | nnMCL (%) . | P value . |
---|---|---|---|---|---|
ATM | 38 | 58 | 0 | <.001∗ | |
Del ATM | 27 | 36 | 0 | <.001∗ | |
Del TP53 | 23 | 14 | 30 | .171 | |
DDR and telomere maintenance | TP53 | 22 | 15 | 25 | .328 |
TERT† | 15 | 10 | 25 | .567 | |
SAMHD1 | 3 | 8 | 0 | .322 | |
del 9p21 (CDKN2A/B) | 31 | 25 | 0 | .009∗ | |
Del 13q14 (RB1) | 25 | 31 | 0 | .004∗ | |
3' UTR CCND1 | 18 | 20 | 15 | NA | |
CCND1 | 16 | 8 | 85 | <.001∗ | |
Gain 8q24 (MYC) | 16 | 12 | 5 | .672 | |
Cell cycle and survival | Gain 12q13 (CDK4) | 13 | 17 | 0 | .058 |
Gain 18q2 (BCL2) | 12 | 19 | 0 | .057 | |
Gain CCND1 | 11 | 14 | 0 | .192 | |
Gain 13q31 (MIR17HG) | 10 | 12 | 0 | .182 | |
Gain 10p12 (BMI1) | 9 | 12 | 0 | .182 | |
KMT2D | 15 | 19 | 0 | .057 | |
NSD2 | 13 | 17 | 0 | .058 | |
Chromatin remodelers | SMARCA4 | 8 | 12 | 0 | .182 |
SP140 | 6 | 8 | 0 | .322 | |
KMT2C | 6 | 0 | 0 | NA | |
BIRC3 | 5 | 5 | 5 | 1 | |
BCR/NF-κB/TLR | CARD11 | 1 | 5 | 5 | 1 |
TRAF2 | 3 | 2 | 0 | .062 | |
NOTCH1 | 7 | 5 | 5 | 1 | |
NOTCH signaling | NOTCH2 | 6 | 5 | 0 | .567 |
UBR5 | 8 | 7 | 0 | .567 | |
SYNE1 | 3 | 5 | 10 | .596 | |
DLC1 | 3 | 2 | 0 | .062 | |
Other | HNRNPH1 | 2 | 7 | 5 | 1 |
MEF2B | 2 | 7 | 0 | .567 | |
S1PR1 | 2 | 5 | 0 | .322 | |
BCOR | 1 | 7 | 0 | .567 | |
Gain 3q25-q29 | 40 | 49 | 10 | .003∗ | |
Del 13q33-q34 | 30 | 42 | 5 | .002∗ | |
Del 1p22 | 30 | 10 | 0 | <.001∗ | |
Del 6q | 20 | 34 | 5 | .017∗ | |
Del 9q22-q31 | 18 | 24 | 0 | .009∗ | |
CNA | Del 8p | 17 | 10 | 5 | .672 |
10p15-p13 del | 15 | 20 | 0 | .031 | |
Del 15q11-q13 | 11 | 12 | 0 | .182 | |
Gain 15q21-q25 | 10 | 10 | 5 | .672 | |
Gain 7p | 9 | 20 | 0 | .031 |
The number of cases used for single nucleotide variant and insertions and deletions (mutations) analyses is 432, based on references Karolová et al35; Yi et al32; Nadeu et al5; Pararjalingam et al36; Jeong et al37; Jain et al33; Agarwal et al38; Yang et al39; Wu et al40; Zhang et al41; Khodadoust et al.42 The number of cases used for CNA is 202, based on references Yi et al32 and Nadeu et al.5 The number of cases used for frequencies among cMCL and nnMCL subtypes is 59 and 20, respectively, based on Nadeu et al5 after eliminating 3 posttreatment samples. Fisher exact test was used to compare the genomic alterations within MCL subgroups. Mutations in genes of late replicating regions43 and IGH, IGK, and IGK loci have been excluded.
Del, deletion; NA, not analyzed; TLR, toll like receptor.
P value ≤ .05 was considered significant.
TERT alterations refer to promoter mutations, structural variants detected by WGS or FISH, and gains or amplifications reported in Nadeu et al.5